Stijn de Zwart
Sr. Legal Counsel & Advocate | Wolters Kluwer | Netherlands
High Times Magazine Files Trademark Infringement Lawsuit
High Times Magazine Files Trademark Infringement Lawsuit By Editorial Team High Times Magazine has initiated legal action alleging trademark infringement against a company that purportedly registered its name to market products such as dog food and alcohol. The magazine is seeking a declaration from a Nevada federal court affirming its ownership rights and requesting the […]
Eli Lilly Appeals $278M Drug Royalties Ruling at 9th Circuit
Eli Lilly Appeals $278M Drug Royalties Ruling at 9th Circuit By Editorial Team Eli Lilly is challenging a ruling that it owes $278 million in drug royalties to an Arizona company for insulin-brand sales. The pharmaceutical giant is arguing that it should not be held accountable for the royalties as it only utilized the company’s […]
Bayer Urges 9th Circ. Not To Revive Tevra Flea, Tick Meds Suit
Bayer Urges 9th Circ. Not To Revive Tevra Flea, Tick Meds Suit By Editorial Team Bayer is urging the Ninth Circuit not to grant a new trial over claims that it locked up the market for pet flea and tick treatment, saying the only evidence that rival Tevra showed a jury at trial was “highly […]
Bayer Urges 9th Circ. Not To Revive Tevra Flea, Tick Meds Suit
Bayer Urges 9th Circ. Not To Revive Tevra Flea, Tick Meds Suit By Editorial Team Bayer is urging the Ninth Circuit not to grant a new trial over claims that it locked up the market for pet flea and tick treatment, saying the only evidence that rival Tevra showed a jury at trial was “highly […]
AbbVie Settles Rinvoq Litigation, Blocks Generics Until 2037
AbbVie Settles Rinvoq Litigation, Blocks Generics Until 2037 By Editorial Team AbbVie Inc. has reached a settlement in litigation with several drug manufacturers, effectively preventing generic versions of its immunosuppressant Rinvoq drug from entering the market until 2037. This settlement concludes the legal battle that accused generic-drug makers of infringing on AbbVie’s patents. The settlement […]
Jazz Loses Bid To Block Avadel From Seeking Sleep Drug Approval
Jazz Loses Bid To Block Avadel From Seeking Sleep Drug Approval By Editorial Team Jazz Pharmaceuticals Inc. has been denied its request to prevent Avadel CNS Pharmaceuticals LLC from pursuing approval from the U.S. Food and Drug Administration (FDA) for its sleep disorder treatment. The ruling came from a Delaware federal judge who stated that […]
You must be logged in to post a comment.